Veraxa Biotech AG Warrants (VRXAW)

• Market cap: $1.23M
• 1 day: 21.13%
• 5 days: 10.74%
• 1 month: 2%
• 3 months: -61.38%
• 6 months: -61.38%
• Year to date: -61.38%
• 1 year: -61.38%
• 5 years: -61.38%
• 10 years: -61.38%
• Sector: Healthcare
• Industry: Biotechnology

About: Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.